# Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome

> **NCT02672592** · PHASE3 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 70 (actual)

## Conditions studied

- Hypogonadism
- Metabolic Syndrome X
- Obesity

## Interventions

- **DRUG:** Anakinra
- **DRUG:** Sodium Chloride 0.9%

## Key facts

- **NCT ID:** NCT02672592
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02672592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02672592, "Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02672592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*